BACKGROUND: We developed a patient decision aid (pDA) to assist psoriasis patients in treatment decisions. OBJECTIVE: This pilot study evaluated the pDA in patient knowledge, decisional conflict, and preparation for decision making. METHODS: Newly referred psoriasis patients in a private dermatology office completed self-administered surveys at three time points: before (visit 1) and on two occasions after provision of the pDA (visit 2 up to 2 weeks after visit 1; visit 3 up to 6 weeks after visit 1). The survey included questions regarding knowledge of psoriasis and its treatment and validated questionnaires on decisional conflict and preparation for decision making. RESULTS: Ten psoriasis patients participated (seven men, three women; mean age 45.7 years), with a mean age of 11.4 years since diagnosis. Improvement by visit 3 was observed for knowledge (p = .06), reduced decisional conflict (p ≤ .001), and preparation for decision making (p ≤ .05). Patients tended to self-select treatment appropriate to the level of psoriasis severity. CONCLUSION: This pilot study of the pDA showed improved patient knowledge of psoriasis and its treatments, reduced decisional conflict, and increased patient preparation for decision making. LIMITATIONS: This small study was not randomized and did not have a comparator arm.
BACKGROUND: We developed a patient decision aid (pDA) to assist psoriasispatients in treatment decisions. OBJECTIVE: This pilot study evaluated the pDA in patient knowledge, decisional conflict, and preparation for decision making. METHODS: Newly referred psoriasispatients in a private dermatology office completed self-administered surveys at three time points: before (visit 1) and on two occasions after provision of the pDA (visit 2 up to 2 weeks after visit 1; visit 3 up to 6 weeks after visit 1). The survey included questions regarding knowledge of psoriasis and its treatment and validated questionnaires on decisional conflict and preparation for decision making. RESULTS: Ten psoriasispatients participated (seven men, three women; mean age 45.7 years), with a mean age of 11.4 years since diagnosis. Improvement by visit 3 was observed for knowledge (p = .06), reduced decisional conflict (p ≤ .001), and preparation for decision making (p ≤ .05). Patients tended to self-select treatment appropriate to the level of psoriasis severity. CONCLUSION: This pilot study of the pDA showed improved patient knowledge of psoriasis and its treatments, reduced decisional conflict, and increased patient preparation for decision making. LIMITATIONS: This small study was not randomized and did not have a comparator arm.
Authors: Alexandra Junn; Neha R Shukla; Lily Morrison; Meghan Halley; Mary-Margaret Chren; Louise C Walter; Dominick L Frosch; Dan Matlock; Jeanette S Torres; Eleni Linos Journal: BMC Med Inform Decis Mak Date: 2020-04-29 Impact factor: 2.796